12 Health Care Stocks Moving In Friday's Intraday Session
Intelligent Bio Solutions Inc INBS
$1.81
▲ +14.92%
(+$0.24)
⬆️ Above Yest. High
🎈 Low Float
🎢 High Beta
Open
$1.58
Prev Close
$1.58
Day Range
$1.57 – $1.92
52W Range
$1.52 – $24.90
Market Cap
$4.33M
Beta
4.25
EPS (TTM)
$-12.52
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-12-23 |
| Shares Out. | 2,390,000 |
| Website | ibs.inc/ ↗ |
| Phone | 13025750877 |
| Employees | 55 |
| Revenue | $1.1M |
| Gross Profit | $535,381 |
| Net Income | -$2.9M |
| Free Cash Flow | -$11.3M |
| Total Assets | $14.9M |
| Total Liabilities | $6.1M |
| Equity | $8.8M |
About Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
Intelligent Bio Solutions Inc is a publicly traded company under the ticker symbol INBS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)